Therapeutic use of MDMA for PTSD and psilocybin for treatment resistant depression

The Royal Australian and New Zealand College of Psychiatrists (RANZCP) has developed this memorandum to provide information for psychiatrists about psychedelic-assisted therapy (PAT) using MDMA to assist in treating PTSD and psilocybin to assist in treating treatment resistant depression (TRD)..... more